三达膜(688101) - 2025 Q1 - 季度财报

Financial Performance - Operating revenue for Q1 2025 was CNY 263,688,492.93, a decrease of 7.26% compared to the same period last year[4] - Net profit attributable to shareholders increased by 14.20% to CNY 76,224,948.98 from CNY 66,745,405.55 in the previous year[4] - Basic and diluted earnings per share rose by 15.00% to CNY 0.23[4] - Total operating revenue for Q1 2025 was ¥263.69 million, a decrease of 7.3% from ¥284.33 million in Q1 2024[19] - Net profit for Q1 2025 reached ¥77.83 million, an increase of 14.0% compared to ¥68.27 million in Q1 2024[20] - Basic and diluted earnings per share for Q1 2025 were both ¥0.23, up from ¥0.20 in Q1 2024[21] - The company reported a total profit of ¥84.80 million for Q1 2025, an increase of 9.4% from ¥77.76 million in Q1 2024[20] Cash Flow and Investments - Net cash flow from operating activities decreased significantly by 78.38% to CNY 12,189,916.56, primarily due to a legal dispute affecting funds[8] - Cash flow from operating activities for Q1 2025 was ¥12.19 million, a significant decrease from ¥56.37 million in Q1 2024[24] - Investment activities generated a net cash outflow of ¥7.02 million in Q1 2025, compared to a net inflow of ¥166.56 million in Q1 2024[24] Assets and Liabilities - Total assets at the end of the reporting period were CNY 6,104,121,847.85, a slight decrease of 0.29% from the previous year[5] - As of March 31, 2025, the company's total assets amounted to RMB 6,104,121,847.85, a slight decrease from RMB 6,121,583,989.79 on December 31, 2024[14][16] - The company's cash and cash equivalents increased to RMB 613,367,267.22 from RMB 571,331,157.05, reflecting a growth of approximately 7.4%[14] - Accounts receivable decreased to RMB 985,262,883.67 from RMB 1,014,535,002.51, indicating a decline of about 2.9%[14] - Total current liabilities decreased to RMB 1,485,509,723.58 from RMB 1,584,686,944.92, a reduction of approximately 6.2%[16] - The company's total equity increased to RMB 4,188,258,571.46 from RMB 4,107,966,847.83, representing a growth of about 1.9%[16] - Long-term equity investments rose to RMB 484,016,189.76 from RMB 468,859,304.70, an increase of approximately 3.2%[15] - The company's inventory increased to RMB 862,334,142.48 from RMB 845,762,768.17, reflecting a growth of about 1.9%[14] - The total liabilities decreased to RMB 1,915,863,276.39 from RMB 2,013,617,141.96, a decline of approximately 4.9%[16] - The company's retained earnings increased to RMB 2,133,136,462.81 from RMB 2,056,911,513.83, showing a growth of about 3.7%[16] - The company reported a total current asset of RMB 3,671,257,790.37, slightly down from RMB 3,682,834,689.23[14] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 11,369[10] - Major shareholders include Sanda Membrane Technology (Singapore) Co., Ltd. with a 43.60% stake and Qingyuan (China) Co., Ltd. with a 25.81% stake[10] Research and Development - R&D investment totaled CNY 12,174,554.56, accounting for 4.62% of operating revenue, a slight increase from 4.61%[5] Other Financial Metrics - The weighted average return on equity increased by 0.13 percentage points to 1.87%[4] - The company reported non-recurring gains of CNY 7,023,492.66 for the period[7] - Other income for Q1 2025 was ¥64,039.24, a decrease from ¥404,542.12 in Q1 2024[20] - The company experienced a credit impairment loss of ¥10.83 million in Q1 2025, compared to a loss of ¥6.66 million in Q1 2024[19]